Abstract
The recently FDA approved AggreGuide A-100 ADP (A100ADP) assay includes appropriate fluid dynamic characteristics in a microfluidic reaction chamber with whole blood in motion to measure P2Y12 inhibitor effects. The ability of the A-100ADP assay to demonstrate P2Y12 inhibitor-induced platelet
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
